Cargando…
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older wi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660568/ https://www.ncbi.nlm.nih.gov/pubmed/31372440 http://dx.doi.org/10.1016/j.dib.2019.103794 |
_version_ | 1783439323854536704 |
---|---|
author | Giustozzi, Michela Vedovati, Maria Cristina Verso, Melina Scrucca, Luca Conti, Serenella Verdecchia, Paolo Bogliari, Giulio Pierpaoli, Lucia Agnelli, Giancarlo Becattini, Cecilia |
author_facet | Giustozzi, Michela Vedovati, Maria Cristina Verso, Melina Scrucca, Luca Conti, Serenella Verdecchia, Paolo Bogliari, Giulio Pierpaoli, Lucia Agnelli, Giancarlo Becattini, Cecilia |
author_sort | Giustozzi, Michela |
collection | PubMed |
description | The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older with non-valvular atrial fibrillation treated with oral anticoagulants. Here, we describe the time course of ischemic stroke and systemic embolism and of major bleeding according to the presence of outcome predictors and report the causes of permanent discontinuation and of death. Furthermore, we report data on the incidence of ischemic stroke and systemic embolism, of major bleeding, of permanent discontinuation and of all-cause death comparing i) oral anticoagulant naïve users vs. long-term oral anticoagulant users, ii) patients on anticoagulant therapy for less than 2 years (new users) vs. patients on anticoagulant therapy for more than 2 years. The material of this data article provides a better understanding on the use of oral anticoagulants in this fragile population and facilitates further critical analysis. Moreover, it aims at highlighting the importance of increasing knowledge in patients aged 90 years or older. These patients are often excluded from or under-represented in clinical trials and cohort studies. |
format | Online Article Text |
id | pubmed-6660568 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-66605682019-08-01 Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation Giustozzi, Michela Vedovati, Maria Cristina Verso, Melina Scrucca, Luca Conti, Serenella Verdecchia, Paolo Bogliari, Giulio Pierpaoli, Lucia Agnelli, Giancarlo Becattini, Cecilia Data Brief Medicine and Dentistry The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data of a cohort of 546 patients aged 90 years or older with non-valvular atrial fibrillation treated with oral anticoagulants. Here, we describe the time course of ischemic stroke and systemic embolism and of major bleeding according to the presence of outcome predictors and report the causes of permanent discontinuation and of death. Furthermore, we report data on the incidence of ischemic stroke and systemic embolism, of major bleeding, of permanent discontinuation and of all-cause death comparing i) oral anticoagulant naïve users vs. long-term oral anticoagulant users, ii) patients on anticoagulant therapy for less than 2 years (new users) vs. patients on anticoagulant therapy for more than 2 years. The material of this data article provides a better understanding on the use of oral anticoagulants in this fragile population and facilitates further critical analysis. Moreover, it aims at highlighting the importance of increasing knowledge in patients aged 90 years or older. These patients are often excluded from or under-represented in clinical trials and cohort studies. Elsevier 2019-03-01 /pmc/articles/PMC6660568/ /pubmed/31372440 http://dx.doi.org/10.1016/j.dib.2019.103794 Text en © 2019 Published by Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Medicine and Dentistry Giustozzi, Michela Vedovati, Maria Cristina Verso, Melina Scrucca, Luca Conti, Serenella Verdecchia, Paolo Bogliari, Giulio Pierpaoli, Lucia Agnelli, Giancarlo Becattini, Cecilia Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title | Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title_full | Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title_fullStr | Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title_full_unstemmed | Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title_short | Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
title_sort | data on the use of oral anticoagulants in nonagenarians with atrial fibrillation |
topic | Medicine and Dentistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660568/ https://www.ncbi.nlm.nih.gov/pubmed/31372440 http://dx.doi.org/10.1016/j.dib.2019.103794 |
work_keys_str_mv | AT giustozzimichela dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT vedovatimariacristina dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT versomelina dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT scruccaluca dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT contiserenella dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT verdecchiapaolo dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT bogliarigiulio dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT pierpaolilucia dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT agnelligiancarlo dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation AT becattinicecilia dataontheuseoforalanticoagulantsinnonagenarianswithatrialfibrillation |